The PE Ratio as of December 2024 (TTM) for Demant A/S (WILYY) is 22.88

According to Demant A/S’s latest financial reports and current stock price. The company's current PE Ratio is 22.88. This represents a change of -2.31% compared to the average of 23.42 of the last 4 quarters.

Demant A/S (WILYY) Historical PE Ratio (quarterly & annually)

How has WILYY PE Ratio performed in the past?

The mean historical PE Ratio of Demant A/S over the last ten years is 29.25. The current 22.88 PE Ratio has changed 7.72% with respect to the historical average. Over the past ten years (40 quarters), WILYY's PE Ratio was at its highest in in the March 2020 quarter at 151.80. The PE Ratio was at its lowest in in the December 2022 quarter at 10.44.

Demant A/S (WILYY) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Demant A/S PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Demant A/S (WILYY) Average PE Ratio

How has WILYY PE Ratio performed in the past?

The current PE Ratio of Demant A/S (WILYY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Demant A/S (WILYY) PE Ratio vs. Peers

How is WILYY’s PE Ratio compared to its peers?

Demant A/S’s PE Ratio is less than Cochlear Limited (54.46), less than GN Store Nord A/S (28.92), less than GN Store Nord A/S (28.92), less than Siemens Healthineers AG (30.05), less than Sonova Holding AG (29.32), greater than CONMED Corporation (16.37), greater than iCAD, Inc. (-13.80), greater than Tivic Health Systems, Inc. (-0.36), greater than Talis Biomedical Corporation (-0.06), greater than Bluejay Diagnostics, Inc. (-4.23), greater than Heart Test Laboratories, Inc. (-443.78), greater than Nuwellis, Inc. (-0.10), greater than CVRx, Inc. (-5.03), greater than Hyperfine, Inc. (-1.52), greater than Inogen, Inc. (-3.80), greater than Accelerate Diagnostics, Inc. (-0.50), greater than Apyx Medical Corporation (-2.15),

Build a custom stock screener for Demant A/S (WILYY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Demant A/S using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Demant A/S (WILYY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Demant A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.